TNFSF13 and myalgic encephalomeyelitis/chronic fatigue syndrome: A proliferation-inducing ligand (APRIL) serum levels were not significantly different in ME/CFS patients compared to healthy controls at baseline, and no changes in serum levels were seen during follow-up.